-
Mashup Score: 54Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC: A Case Exploration of New Standards and Emerging Approaches - 30 day(s) ago
See the latest #NSCLC live event from @PeerView @jdoningtonmd @DoctorJSpicer #AATS2024 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 23Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC: A Case Exploration of New Standards and Emerging Approaches - 1 month(s) ago
See the latest #NSCLC live event from @PeerView @jdoningtonmd @DoctorJSpicer #AATS2024 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Cardiology News and JournTweet
SPONSORED: Updates on the latest evidence supporting (neo)adjuvant and #Perioperative #Immunotherapy for resectable #NSCLC. Saturday, April 27th at 12:00 PM EDT during #AATS2024. Featuring @jdoningtonmd & @DoctorJSpicer! https://t.co/g50wMigN1e https://t.co/6CGkAJqVzY